These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 12940904)

  • 1. Dose determinants in continuous renal replacement therapy.
    Clark WR; Turk JE; Kraus MA; Gao D
    Artif Organs; 2003 Sep; 27(9):815-20. PubMed ID: 12940904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure.
    Saudan P; Niederberger M; De Seigneux S; Romand J; Pugin J; Perneger T; Martin PY
    Kidney Int; 2006 Oct; 70(7):1312-7. PubMed ID: 16850022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent versus continuous treatment for acute renal failure: where do we stand?
    van Bommel EF; Ponssen HH
    Am J Kidney Dis; 1997 Nov; 30(5 Suppl 4):S72-9. PubMed ID: 9372982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the impact of renal replacement therapy choice on outcome in severe acute renal failure.
    Swartz RD; Bustami RT; Daley JM; Gillespie BW; Port FK
    Clin Nephrol; 2005 May; 63(5):335-45. PubMed ID: 15909592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy].
    Gong D; Ji D; Xie H; Xu B; Liu Y; Li L
    Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):183-6. PubMed ID: 11798577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit.
    Davenport A
    Am J Kidney Dis; 1997 Nov; 30(5 Suppl 4):S20-7. PubMed ID: 9372975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predilution versus postdilution continuous venovenous hemofiltration: no effect on filter life and azotemic control in critically ill patients on heparin.
    Nurmohamed SA; Jallah BP; Vervloet MG; Beishuizen A; Groeneveld AB
    ASAIO J; 2011; 57(1):48-52. PubMed ID: 21084966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal Mode of clearance in critically ill patients with Acute Kidney Injury (OMAKI)--a pilot randomized controlled trial of hemofiltration versus hemodialysis: a Canadian Critical Care Trials Group project.
    Wald R; Friedrich JO; Bagshaw SM; Burns KE; Garg AX; Hladunewich MA; House AA; Lapinsky S; Klein D; Pannu NI; Pope K; Richardson RM; Thorpe K; Adhikari NK
    Crit Care; 2012 Oct; 16(5):R205. PubMed ID: 23095370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose in continuous renal replacement therapy.
    Claure-Del Granado R
    Gac Med Mex; 2018; 154(Supp 1):S40-S47. PubMed ID: 30074025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.
    Pea F; Viale P; Pavan F; Furlanut M
    Clin Pharmacokinet; 2007; 46(12):997-1038. PubMed ID: 18027987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What dialysis dose should be provided in acute renal failure? A review.
    Leblanc M; Tapolyai M; Paganini EP
    Adv Ren Replace Ther; 1995 Jul; 2(3):255-64. PubMed ID: 7614362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended Daily Dialysis Versus Continuous Renal Replacement Therapy for Acute Kidney Injury: A Meta-analysis.
    Zhang L; Yang J; Eastwood GM; Zhu G; Tanaka A; Bellomo R
    Am J Kidney Dis; 2015 Aug; 66(2):322-30. PubMed ID: 25843704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription and Delivery of the Right Continuous Renal Replacement Therapies Dose.
    Villa G; Neri M; Ronco C; Cerdá J
    Contrib Nephrol; 2018; 194():38-50. PubMed ID: 29597217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification and Dosing of Renal Replacement Therapy in Acute Kidney Injury: A Reappraisal.
    Clark WR; Leblanc M; Ricci Z; Ronco C
    Blood Purif; 2017; 44(2):140-155. PubMed ID: 28586767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of solute clearance in three modes of continuous renal replacement therapy.
    Parakininkas D; Greenbaum LA
    Pediatr Crit Care Med; 2004 May; 5(3):269-74. PubMed ID: 15115566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review and meta-analysis of renal replacement therapy modalities for acute kidney injury in the intensive care unit.
    Nash DM; Przech S; Wald R; O'Reilly D
    J Crit Care; 2017 Oct; 41():138-144. PubMed ID: 28525779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic comparison of different acute dialysis therapies.
    Liao Z; Zhang W; Hardy PA; Poh CK; Huang Z; Kraus MA; Clark WR; Gao D
    Artif Organs; 2003 Sep; 27(9):802-7. PubMed ID: 12940902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill].
    Morabito S; Pistolesi V; Cibelli L; Pierucci A
    G Ital Nefrol; 2009; 26(1):13-21. PubMed ID: 19255959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous Renal Replacement Therapy: Reviewing Current Best Practice to Provide High-Quality Extracorporeal Therapy to Critically Ill Patients.
    Connor MJ; Karakala N
    Adv Chronic Kidney Dis; 2017 Jul; 24(4):213-218. PubMed ID: 28778360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal replacement therapy and acute renal failure.
    Quan A; Quigley R
    Curr Opin Pediatr; 2005 Apr; 17(2):205-9. PubMed ID: 15800413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.